Novo Nordisk - Digital Transformation Strategies

Novo Nordisk - Digital Transformation Strategies

Summary

Novo Nordisk AS (Novo Nordisk), a subsidiary of Novo Holdings AS, is a healthcare company focused on discovering, developing, and manufacturing of innovative biological medicines. It focuses on advancing drugs for the treatment of diabetes and other serious chronic conditions, including hemophilia, human growth hormone (HGH) disorders, rare blood and rare endocrine diseases, and obesity. The company’s portfolio includes pre-filled delivery systems for insulin; glucagon hypokit; cartridge; needles; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. The company markets its products through subsidiaries in North America, Europe, Asia, Latin America, Africa, the Middle East, and Australia.

The report provides information and insights into Novo Nordisk's tech activities, including -

• Insights of its digital transformation strategies and innovation programs
• Overview of technology initiatives covering partnerships, product launches and acquisitions
• Insights on each technology initiative including technology theme, objective, and benefits
• Details of estimated ICT budgets and major ICT contracts

Scope

• Novo Nordisk implemented mixed reality technology in its manufacturing facilities to enhance processes and improve performance. This technology facilitates better instructions to employees that guide them through complex tasks or training.
• Novo Nordisk's Modelling and Predictive Technologies department applies advanced protein modelling and data science tools to design novel medicines. They utilize machine learning and deep-learning AI algorithms to automate cognitive tasks and enhance drug creation processes.
• Novo Nordisk collaborated with Microsoft to combine Microsoft's computational services, cloud infrastructure, and artificial intelligence (AI) capabilities with its expertise in drug discovery, development, and data science.
• As a part of its transformation strategy and to improve customer experience, Novo Nordisk implemented an Omnichannel Customer Experience Hub which is powered by Adobe's real-time customer data platform (CDP).

Reasons to Buy

• Gain insights into Novo Nordisk's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships and acquisition strategies.